FTC May Turn Away From Court For Complex Conduct Suits
After the Federal Trade Commission faced several recent setbacks in pursuing pay-for-delay challenges in federal court, cases challenging pharmaceutical companies and others over complicated conduct are more likely to end up...To view the full article, register now.
Already a subscriber? Click here to view full article